日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細

  Molecular and functional imaging technology for the development of efficient treatment strategies for gliomas

Jacobs, A. H., Winkeler, A., Dittmar, C., Gossmann, A., Deckert, M., Kracht, L., Thiel, A., Garlip, G., Hilker, R., Vollmar, S., Kummer, C., Graf, R., Voges, J., Wienhard, K., Herholz, K., & Heiss, W.-D. (2002). Molecular and functional imaging technology for the development of efficient treatment strategies for gliomas. Technology in Cancer Research and Treatment, 1(3), 187-204.

Item is

基本情報

表示: 非表示:
資料種別: 学術論文

ファイル

表示: ファイル

関連URL

表示:

作成者

表示:
非表示:
 作成者:
Jacobs, Andreas H.1, 著者           
Winkeler, A.1, 著者           
Dittmar, C., 著者
Gossmann, A., 著者
Deckert, M., 著者
Kracht, Lutz2, 著者           
Thiel, Alexander2, 著者           
Garlip, G., 著者
Hilker, Rüdiger3, 著者
Vollmar, Stefan4, 著者           
Kummer, Christiane5, 著者           
Graf, Rudolf6, 著者           
Voges, J., 著者
Wienhard, Klaus5, 著者           
Herholz, Karl5, 著者           
Heiss, Wolf-Dieter5, 著者           
所属:
1Gentherapie und Molekulare Bildgebung, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149662              
2Klinisches PET, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149663              
3Max Planck Society, ou_persistent13              
4IT and Electronics Dev., Scientific Services and Development, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149670              
5Wolf-Dieter Heiss, Emeriti, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149649              
6Multimodal Imaging of Brain Metabolism, Research Groups, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149667              

内容説明

表示:
非表示:
キーワード: -
 要旨: Gliomas are the most common types of brain tumors, which invariably lead to death over months or years. Before new and potentially more effective treatment strategies, such as gene therapy, can be effectively introduced into clinical application the following goals must be reached: (1) the determination of localization, extent and metabolic activity of the glioma; (2) the assessment of functional changes within the surrounding brain tissue; (3) the identification of genetic changes on the molecular level leading to disease; and in addition (4) a detailed non-invasive analysis of both endogenous and exogenous gene expression in animal models and in the clinical setting. Non-invasive imaging of endogenous gene expression by means of positron emission tomography (PET) may reveal insight into the molecular basis of pathogenesis and metabolic activity of the glioma and the extent of treatment response. When exogenous genes are introduced to serve for a therapeutic function, PET imaging techniques may reveal the assessment of the location, magnitude and duration of therapeutic gene expression and its relation to the therapeutic effect. Here, we review the main principles of PET imaging and its key roles in neurooncology research

資料詳細

表示:
非表示:
言語: eng - English
 日付: 2002
 出版の状態: 出版
 ページ: -
 出版情報: -
 目次: -
 査読: 査読あり
 識別子(DOI, ISBNなど): eDoc: 34992
 学位: -

関連イベント

表示:

訴訟

表示:

Project information

表示:

出版物 1

表示:
非表示:
出版物名: Technology in Cancer Research and Treatment
  出版物の別名 : Technol Cancer Res Treat.
種別: 学術雑誌
 著者・編者:
所属:
出版社, 出版地: -
ページ: - 巻号: 1 (3) 通巻号: - 開始・終了ページ: 187 - 204 識別子(ISBN, ISSN, DOIなど): -